Project Grant H79SM091113
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the University of California, Irvine $650,000 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (SED) program (CFDA 93.104) to establish IEDAPT-CHR-P, a countywide stepped-care program identifying and treating 155 youth and young adults ages 12–25 at clinical high risk for psychosis in Orange County, California. The program, housed within...
- SAMHSA's Center for Mental Health Services awarded $650,000 to the Health Services Kentucky Cabinet For on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104) to establish the Clinical High Risk for Psychosis STRONG (Supporting Treatment, Resiliency, Outreach, Networking, and Growth) Initiative. The project will implement screening, assessment, stepped-care intervention, shared decision-making, family...
- The Substance Abuse and Mental Health Services Administration awarded $600,000 to Child Mind Institute Inc. on September 30, 2026, under the Center for Mental Health Services Projects of Regional and National Significance program (CFDA 93.532). Child Mind Institute will adapt, manualize, evaluate, and nationally disseminate RISE (Recognize, Identify, Soothe, and Empower), a dialectical behavior therapy-informed, trauma-responsive emotion regulation protocol for school-based and...
- The Substance Abuse and Mental Health Services Administration awarded the Massachusetts Department of Mental Health $650,000 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104) to support the Massachusetts Psychosis Prevention Partnership (M3P). M3P is a statewide initiative to identify youth and young adults at clinical high risk for psychosis and provide evidence-based stepped-care...
- The National Institute of Mental Health awarded The Feinstein Institutes For Medical Research $460,625 on July 24, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct network analysis research on clinical high risk for psychosis populations. The award funds a research project examining the interplay of clinical symptoms, neurocognition, functioning, and stressful events in individuals at clinical high risk for developing psychosis using network theory. The research...
- The Department of Health and Human Services Substance Abuse and Mental Health Services Administration awarded $1.795587 million to County of Schoharie on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (SED) program (CFDA 93.104). County of Schoharie will implement a countywide system of care to improve access to coordinated behavioral health services for children and youth ages 5–21 with or at risk for serious...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Connecticut Department of Mental Health and Addiction Services $649,999 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104) to operate the PRIME Clinic, a statewide early-psychosis detection and intervention program serving Connecticut youth aged 12–25 at clinical high risk for psychosis (CHR-P). The PRIME program...
- The Substance Abuse and Mental Health Services Administration awarded The Harris Center For Mental Health & IDD $481,923 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104) to establish the Clinical High Risk Psychosis Program (CHRP), a stepped-care model for assessment and treatment of clinical high risk for psychosis in individuals ages 10 to 25 in Harris County, Texas. The program implements...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded My Health My Resources of Tarrant County $650,000 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (SED) program (CFDA 93.104) to implement the Tarrant County Clinical High Risk for Psychosis (CHR-P) initiative. The recipient will operate a community-based program designed to identify and intervene early with youth and young adults ages 14...
- The National Institute of Mental Health awarded Research Foundation For Mental Hygiene, Inc. (operating as New York State Psychiatric Institute) $414,186 on August 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to pilot-test an expanded service delivery model for suicide risk identification and behavioral health treatment linkage among youth on probation. The award funds a three-year hybrid effectiveness-implementation study that augments an existing systems-level...
The Substance Abuse and Mental Health Services Administration awarded the Research Foundation for Mental Hygiene, Inc. (operating through the New York State Psychiatric Institute) $650,000 on September 30, 2026, under the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances program (CFDA 93.104). SWAY (Supporting Wellness for Adolescents and Young Adults at Clinical High Risk for Psychosis) delivers evidence-based stepped-care services to 25–30 youth and young adults ages 12–25 at clinical high risk for psychosis and their families annually across the New York City metro area and Long Island. The award funds a renewal establishing a Clinical High Risk for Psychosis Center of Excellence—a scalable training and clinical resource hub offering web-based modules, a video library, and direct outreach to 30+ community clinicians and 7,500+ youth and families per year. The service population is racially and ethnically heterogeneous (31% White, 28% Black, 22% Asian, 16% Multiracial; 19% Hispanic/Latino), with 23% speaking a non-English language at home. Clinical presentation includes 67% meeting attenuated psychosis syndrome criteria, 53% with lifetime trauma exposure (30% probable PTSD), and high prevalence of co-occurring depression and anxiety. Year 1 enrollment continues 27 actively enrolled participants from the prior award phase; Years 2–4 serve 30 participants annually for a total of 115 across the four-year period. Performance period runs from September 30, 2026, through September 29, 2030, with place of performance at New York, NY 10032. This is an assistance type Project Grant, a continuation of SAMHSA award 1H79SM086136.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $650.0k | 8/12/26 |